Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01062685 · ClinicalTrials.gov registry record
Near Infrared Spectroscopy (St02)
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 186
- Enrollment target
NCT01062685: Completed study, sponsored by Beth Israel Deaconess Medical Center.
NCT01062685 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 186 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01062685 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 186 participants
- Enrollment target
Study Summary
The overall hypotheses of this project is that Near Infrared Spectroscopy (NIRS) can be used to identify morbidity, mortality, and resource utilization in patients with sepsis and septic shock.
Interventions
- DIAGNOSTIC_TEST Near-infrared spectroscopy assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-01 |
What the finished NCT01062685 record still lists
NCT01062685 is an observational study that tracks outcomes without assigning an intervention. The registered 186 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Near-infrared spectroscopy assessment is the first listed.
NCT01062685 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01062685 about?
NCT01062685 is a clinical study titled "Near Infrared Spectroscopy (St02)". The overall hypotheses of this project is that Near Infrared Spectroscopy (NIRS) can be used to identify morbidity, mortality, and resource utilization in patients with sepsis and septic shock.
What is the current status of trial NCT01062685?
This trial is currently completed. The enrollment target is 186 participants. The study started on 2009-01. Estimated completion is 2010-01.
What interventions are being tested in trial NCT01062685?
The interventions under investigation include: Near-infrared spectroscopy assessment (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01062685?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03567889 · 186 participants · Phase 3
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- NCT05281471 · 186 participants · Phase 3
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- NCT05405595 · 186 participants · Phase 1
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
- NCT05762107 · 186 participants · Phase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia